Back to
Market shaping goal indicators
To shape markets for vaccines and other immunisation products
To shape markets for vaccines and other immunisation products
Sufficient and uninterrupted supply
What we measure: Number of Gavi vaccine markets where supply of appropriate vaccines is both sufficient and uninterrupted to meet demand.
Cost of fully vaccinating a child with pentavalent, pneumococcal and rotavirus vaccines
What we measure: The weighted average vaccine price of fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines.
Innovation
What we measure: Number of vaccines and other related products with improved characteristics procured compared with the baseline year.
Healthy market dynamics
What we measure: Number of Gavi vaccine markets classified as benefiting from high or moderate health. Each vaccine market is rated as having high, moderate or low market health, or as having no healthy market dynamics.
Some figures from previous years have been updated due to revisions of historical data.
Our 2016-2020 strategy
The market shaping goal (Phase 4)
Shape markets for vaccines and other immunisation products
Last updated: 4 Dec 2019